XML 46 R61.htm IDEA: XBRL DOCUMENT v2.4.0.8
Inventories Inventories- Schedule of Inventories (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Inventory Disclosure [Abstract]    
Raw materials $ 489 $ 3,754
Work-in-process 9,981 11,317
Finished goods 3,677 15,393
Total $ 14,147 [1] $ 30,464 [1]
[1] Amounts as of December 31, 2012 include the assets and liabilities of Vertex’s variable interest entity (“VIE”), Alios BioPharma, Inc. (“Alios”). The Company deconsolidated Alios as of December 31, 2013. Vertex’s interests and obligations with respect to the VIE’s assets and liabilities are limited to those accorded to Vertex in its agreement with Alios. See Note B, "Collaborative Arrangements," to these consolidated financial statements for amounts.